Memphis, TN, United States of America

R Kip Guy


Average Co-Inventor Count = 6.7

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Memphis, TN (US) (2013)
  • Lexington, KY (US) (2021 - 2023)

Company Filing History:


Years Active: 2013-2023

Loading Chart...
3 patents (USPTO):Explore Patents

Title: R Kip Guy: Innovator in Bromodomain Inhibitors

Introduction

R Kip Guy is a notable inventor based in Memphis, TN (US), recognized for his contributions to the field of medicinal chemistry. He holds three patents, showcasing his innovative approach to developing compounds that can potentially address serious health issues, including cancer.

Latest Patents

Among his latest patents are the Tetrahydroquinoline-based bromodomain inhibitors. These patents disclose compounds and compositions that modulate a bromodomain, along with methods for making and using these compounds. The disclosed compounds and compositions are particularly useful for disorders associated with the inhibition of a bromodomain, such as cancer. This information serves as a scanning tool for those searching within this specific area of research.

Career Highlights

R Kip Guy has made significant strides in his career, particularly through his work at esteemed institutions. He has been associated with St. Jude Children's Research Hospital, where he contributed to groundbreaking research. Additionally, he has worked at Leiden University Medical Center, further enhancing his expertise in the field.

Collaborations

Throughout his career, R Kip Guy has collaborated with notable colleagues, including P Jake Slavish and William Robert Shadrick. These collaborations have likely enriched his research and contributed to his innovative outputs.

Conclusion

R Kip Guy's work in developing bromodomain inhibitors highlights his commitment to advancing medical science. His patents and collaborations reflect a dedication to addressing critical health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…